Amber Bio is a biotechnology company pioneering new gene editing modalities.
Amplifyer Bio is developing technology of transformative potential for the liquid biopsy field.
Arvada is a drug discovery and development company committed developing medicines for patients with abnormal heart rhythms.
Edison Scientific, a spin out from FutureHouse, is accelerating discovery across the sciences with Kosmos, its AI scientist that compresses months of research into a single run.
Metri Bio is pioneering therapeutics for endometrial disease to improve the lives of people suffering from endometriosis and uterine diseases.
Skeletalis is building the future of bone health by accelerating the delivery of new medicines to patients, and expanding what’s possible in women’s health and beyond.
Thymmune is a biotechnology company developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease.